About Eu-PIC

Implementing and supporting Pharmacogenetics for the most important and actionable  pharmacogenetic markers into clinical care and monitor uptake and experiences.

Psychiatry, Internal Medicine, Cardiology and Oncology. 



  • Participating countries

    • Netherlands
    • Austria
    • Belgium
    • Denmark
    • Finland
    • France
    • Germany
    • Greece
    • Hungary
    • Italy
    • Poland
    • Portugal
    • Slovenia
    • Spain
    • Sweden
    • Switserland
    • Turkey
    • UK


Advisory Board

You can be an active participant from an organization or be a private partner.
This email address is being protected from spambots. You need JavaScript enabled to view it. or fill in the contactform.

Prof Dr Michel Eichelbaum, PhD/MD
IKP Stuttgart (DE)
Internal Medicine, Clinical Pharmacology

Prof Dr Mary Relling, PhD/PharmD 
CPIC/St Jude’s Memphis (USA)
Pharmaceutical sciences

Dr Dick Weinshilboum , PhD/MD
Mayo Clinic (USA)

Prof Dr Barbara Prainsack, PhD 
King’s College London
Science & Regulation

Prof Dr Sander Vinks, PharmD/PhD
Cincinatti  Children’s Hospital (USA)
Director Div Clinical Pharmacology

Dr Maarten Akkerman, PhD 
ACHMEA Health Insurance (NL)

Prof Dr Cecile Janssens, PhD
Emory University (USA)
Translational Epidemiology

Prof Dr Bert Leufkens
College ter Beoordeling van geneesmiddelen (CBG) (NL)
Hospital Pharmacist & Epidemiologist

Prof Dr Barbara Zehnbauer, PhD, FACMG, FACB
Center for Surveillance, Epidemiology and Laboratory Services (CDC) (USA)
Acting Director Div Laboratory Programs, Standards and Services


Dr. Issam Zineh 
Office Director Clinical Pharmacology FDA


Prof. Dr. John van den Anker 
President Elect American College for Clinical Pharmacology


Prof. Dr. Krisna Prasad
Chair European Medicine Agency Pharmacoegenomuics Working Party


Prof. Dr.  Wolfgang Gaebel

President European Psychiatry Association


Dr. Isa Houwink, MD/PhD

General practitioner (GP) & RIVM/VUmc 
PostDoc "Personalized medicine, eligible or not?"